Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells

<p>Abstract</p> <p>Background</p> <p>Signal transducers and activators of transcription (STATs) are involved in growth regulation of cells. They are usually activated by phosphorylation at specific tyrosine residues. In neoplastic cells, constitutive activation of STATs...

Full description

Bibliographic Details
Main Authors: Barton Arnold B, Shu Ping, Murphy Thomas F, Huang Hosea F, Barton Beverly E
Format: Article
Language:English
Published: BMC 2005-01-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/4/1/2
id doaj-86621d1fa2f648b7bd068ce1b2f0d1f9
record_format Article
spelling doaj-86621d1fa2f648b7bd068ce1b2f0d1f92020-11-25T01:31:58ZengBMCMolecular Cancer1476-45982005-01-0141210.1186/1476-4598-4-2Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cellsBarton Arnold BShu PingMurphy Thomas FHuang Hosea FBarton Beverly E<p>Abstract</p> <p>Background</p> <p>Signal transducers and activators of transcription (STATs) are involved in growth regulation of cells. They are usually activated by phosphorylation at specific tyrosine residues. In neoplastic cells, constitutive activation of STATs accompanies growth dysregulation and resistance to apoptosis through changes in gene expression, such as enhanced anti-apoptotic gene expression or reduced pro-apoptotic gene expression. Activated STAT3 is thought to play an important role in prostate cancer (PCA) progression. Because we are interested in how persistently-activated STAT3 changes the cellular phenotype to a malignant one in prostate cancer, we used expression vectors containing a gene for constitutively-activated STAT3, called S3c, into NRP-152 rat and BPH-1 human benign prostatic epithelial cells.</p> <p>Results</p> <p>We observed that prostatic cell lines stably expressing S3c required STAT3 expression for survival, because they became sensitive to antisense oligonucleotide for STAT3. However, S3c-transfected cells were not sensitive to the effects of JAK inhibitors, meaning that STAT3 was constitutively-activated in these transfected cell lines. NRP-152 prostatic epithelial cells lost the requirement for exogenous growth factors. Furthermore, we observed that NRP-152 expressing S3c had enhanced mRNA levels of retinoic acid receptor (RAR)-α, reduced mRNA levels of RAR-β and -γ, while BPH-1 cells transfected with S3c became insensitive to the effects of androgen, and also to the effects of a testosterone antagonist. Both S3c-transfected cell lines grew in soft agar after stable transfection with S3c, however neither S3c-transfected cell line was tumorigenic in severe-combined immunodeficient mice.</p> <p>Conclusions</p> <p>We conclude, based on our findings, that persistently-activated STAT3 is an important molecular marker of prostate cancer, which develops in formerly benign prostate cells and changes their phenotype to one more closely resembling transformed prostate cells. That the S3c-transfected cell lines require the continued expression of S3c demonstrates that a significant phenotypic change occurred in the cells. These conclusions are based on our data with respect to loss of growth factor requirement, loss of androgen response, gain of growth in soft agar, and changes in RAR subunit expression, all of which are consistent with a malignant phenotype in prostate cancer. However, an additional genetic change may be required for S3c-transfected prostate cells to become tumorigenic.</p> http://www.molecular-cancer.com/content/4/1/2
collection DOAJ
language English
format Article
sources DOAJ
author Barton Arnold B
Shu Ping
Murphy Thomas F
Huang Hosea F
Barton Beverly E
spellingShingle Barton Arnold B
Shu Ping
Murphy Thomas F
Huang Hosea F
Barton Beverly E
Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
Molecular Cancer
author_facet Barton Arnold B
Shu Ping
Murphy Thomas F
Huang Hosea F
Barton Beverly E
author_sort Barton Arnold B
title Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
title_short Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
title_full Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
title_fullStr Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
title_full_unstemmed Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
title_sort stable expression of constitutively-activated stat3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2005-01-01
description <p>Abstract</p> <p>Background</p> <p>Signal transducers and activators of transcription (STATs) are involved in growth regulation of cells. They are usually activated by phosphorylation at specific tyrosine residues. In neoplastic cells, constitutive activation of STATs accompanies growth dysregulation and resistance to apoptosis through changes in gene expression, such as enhanced anti-apoptotic gene expression or reduced pro-apoptotic gene expression. Activated STAT3 is thought to play an important role in prostate cancer (PCA) progression. Because we are interested in how persistently-activated STAT3 changes the cellular phenotype to a malignant one in prostate cancer, we used expression vectors containing a gene for constitutively-activated STAT3, called S3c, into NRP-152 rat and BPH-1 human benign prostatic epithelial cells.</p> <p>Results</p> <p>We observed that prostatic cell lines stably expressing S3c required STAT3 expression for survival, because they became sensitive to antisense oligonucleotide for STAT3. However, S3c-transfected cells were not sensitive to the effects of JAK inhibitors, meaning that STAT3 was constitutively-activated in these transfected cell lines. NRP-152 prostatic epithelial cells lost the requirement for exogenous growth factors. Furthermore, we observed that NRP-152 expressing S3c had enhanced mRNA levels of retinoic acid receptor (RAR)-α, reduced mRNA levels of RAR-β and -γ, while BPH-1 cells transfected with S3c became insensitive to the effects of androgen, and also to the effects of a testosterone antagonist. Both S3c-transfected cell lines grew in soft agar after stable transfection with S3c, however neither S3c-transfected cell line was tumorigenic in severe-combined immunodeficient mice.</p> <p>Conclusions</p> <p>We conclude, based on our findings, that persistently-activated STAT3 is an important molecular marker of prostate cancer, which develops in formerly benign prostate cells and changes their phenotype to one more closely resembling transformed prostate cells. That the S3c-transfected cell lines require the continued expression of S3c demonstrates that a significant phenotypic change occurred in the cells. These conclusions are based on our data with respect to loss of growth factor requirement, loss of androgen response, gain of growth in soft agar, and changes in RAR subunit expression, all of which are consistent with a malignant phenotype in prostate cancer. However, an additional genetic change may be required for S3c-transfected prostate cells to become tumorigenic.</p>
url http://www.molecular-cancer.com/content/4/1/2
work_keys_str_mv AT bartonarnoldb stableexpressionofconstitutivelyactivatedstat3inbenignprostaticepithelialcellschangestheirphenotypetothatresemblingmalignantcells
AT shuping stableexpressionofconstitutivelyactivatedstat3inbenignprostaticepithelialcellschangestheirphenotypetothatresemblingmalignantcells
AT murphythomasf stableexpressionofconstitutivelyactivatedstat3inbenignprostaticepithelialcellschangestheirphenotypetothatresemblingmalignantcells
AT huanghoseaf stableexpressionofconstitutivelyactivatedstat3inbenignprostaticepithelialcellschangestheirphenotypetothatresemblingmalignantcells
AT bartonbeverlye stableexpressionofconstitutivelyactivatedstat3inbenignprostaticepithelialcellschangestheirphenotypetothatresemblingmalignantcells
_version_ 1725084146385027072